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Purpose: To establish a robust method to isolate primary retinal ganglion cells (RGCs) from human fetal retina for long-
term culture while maintaining neuronal morphology and marker protein expression.
Methods: A total of six human retinas were obtained from aborted fetuses at 10 to 12 weeks of gestation with informed
consent from mothers. RGCs were isolated and purified by a modified two-step immunopanning procedure. The cells
were maintained in a serum-free defined medium supplemented with brain-derived neurotrophic factor, ciliary neutrophic
factor, and forskolin. The viable RGCs and the extent of neurite outgrowth were examined by calcein-acetoxymethylester
assay. Expression of RGC markers was studied by immunocytochemistry.
Results: Primary RGCs from human fetal retinas were isolated and maintained in vitro for one month with substantial
neurite elongation. In cell culture, almost 70% of the isolated cells attached, spread, and displayed numerous dendrites.
They were immunoreactive to RGC-specific markers (Thy-1, TUJ-1, and Brn3a) and negative for glial fibrillary acidic
protein and amacrine cells marker HPC-1.
Conclusions: Human RGCs were successfully isolated and maintained in long-term culture. This can serve as an ideal
model for biologic, toxicological, and genomic assays of human RGCs in vitro.
Retinal ganglion cells (RGCs) are the sole output neurons
from the eyes, assuming the critical role of transmitting visual
signals to the higher visual center at the brain cortex before
signal processing [1]. They are the most important ocular
cells; their anatomic or functional impairment is responsible
for the development of most, if not all, ocular diseases and
dysfunctions. The irreversible death of RGCs is associated
with, or a consequence of, many ocular diseases, such as
glaucoma  and  age-related  macular  degeneration  (AMD),
which are the leading causes of blindness worldwide [2].
Ocular  neurodegeneration  is  rapidly  becoming  a  global
burden  on  the  economy,  social  wellbeing,  and  the
sustainability of health care systems. The mechanisms of RGC
degeneration or death are complicated and current knowledge
does not explain the disease-related RGC changes. How the
morphological or functional changes of RGCs contribute to
the  development  of  diabetic  retinopathy  or  glaucomatous
optic neuropathy is largely unknown [3]. Accordingly, if the
missing link between the cytopathological changes in RGCs
and the development of glaucoma can be determined, studies
about growth factors and RGC ion channel blockers may open
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up  avenues  for  therapeutic  neuroprotection  [4].  Hence,
dendritic growth, regeneration, and synapse formation are the
most essential parameters for assessment of the cytoprotective
or  cytotoxic  effects  of  various  chemical  molecules  or
exogenous pharmacological agents.
In view of the high research value of studying mammalian
RGCs, there have been many studies on the early passages of
mammalian  RGCs  in  short-term  explant  culture  [5-7].
Nevertheless, a mixed culture of different retinal cell types
hinders a clear interpretation of the underlying cellular and
molecular pathways attributed to RGCs. Moreover, poor cell
viability due to cytokines released from dying cells in explants
was a major drawback [8]. Enriched by a protocol reported in
Barres et al. [9-11], RGCs and their culture were employed
for  studying  intracellular  signaling.  The  examination  of
neurite parameters, such as spanning area, neurite length, and
branching,  became  technically  feasible  providing  an
objective,  quantifiable,  and  reproducible  measurement  for
studies on cell physiology and the pathophysiology of RGCs
[8]. Transformed RGC lines may offer cells for studies on
protein  and  RNA  expressions  but  the  lack  of  essential
morphological  and  physiologic  features  of  transformed
RGCs, such as no dendritic processes or different patterns of
electro-excitation  and  cytotoxicity,  limit  their  usefulness
[12].
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2867There is a mounting need to develop a more versatile
protocol for purification and long-term culture of primary
human RGCs. In this study, we introduce a novel isolation
technique  using  two-step  immunopanning  for  harvesting
human RGCs from fetal retinas and a sustained culture of
RGCs  with  good  preservation  of  neurite  morphology  and
marker protein expression.
METHODS
Human fetal retinal tissue: This research adhered to the tenets
of the Declaration of Helsinki. With consent from the mothers,
six fetal eyes were obtained from the donors, aborted at 10 to
12 weeks of gestation. These eyes were collected in sterile
Neurobasal  medium  (Invitrogen,  Carlsbad,  CA)
supplemented with 200  μg/ml penicillin G and 200 U/ml
streptomycin sulfate (Invitrogen) on ice.
Purification  of  retinal  ganglion  cells:  The  protocol  was
adapted from RGC purification of adult rat retina [9,10] with
modifications.  A  two-step  immunopanning  procedure  was
performed.
Step 1. Dissociation of retina—Eye cups were dissected
at the pars plana position, the retina was peeled from retinal
pigment epithelium and trimmed to small pieces in Hank’s
balanced salt solution (HBSS, Invitrogen) on ice. After gentle
washing,  the  retinal  pieces  were  incubated  in  an  enzyme
cocktail containing 70 U/ml crude collagenase (catalog no.
C0130; Sigma, St Louis, MO), 15 U/ml papain (catalog no.
P4762; Sigma), 0.2 mg/ml L-cysteine and 0.02% BSA (BSA;
Sigma) for 10 min at 37 °C with gentle agitation. The cell
suspension was triturated (vol:vol ratio of 1:5) with OVO-1
solution with 2 mg/ml Ovomucoid (catalog no. T2011; Sigma)
and 1 mg/ml BSA in HBSS. It was further triturated (vol:vol
ratio of 2:1) with OVO-2 solution with 10 mg/ml Ovomucoid
and 10 mg/ml BSA in HBSS to yield a single cell suspension.
After centrifugation, single cells were resuspended in HBSS
containing 0.5 mg/ml BSA.
Step 2. Two-step immunopanning for RGCs—Sterile
culture  dishes  (100  mm  in  diameter;  Nunc,  Roskilde,
Rochester,  NY)  were  prepared  for  immunopanning.  They
were coated with 10 µg/ml affinity-purified goat anti-mouse
IgG (H+L) antibody (Jackson Immunology Lab, West Grove,
PA) in 50 mM Tris (pH 9.5) at 4 °C overnight. After washing,
the dish surface was blocked with 0.2 mg/ml BSA in 0.01 M
PBS for 20 min. The dishes were then incubated with mouse
anti-rat Thy1.1 antibody (2 µg/ml; catalog no. MAB1406;
Chemicon, Temecula, CA) for 2 h at room temperature. After
washing, the Thy1.1 antibody-coated dishes were stored at
4 °C and used within 2 days.
The retinal cell suspension was incubated with mouse
anti-rat  macrophage  antiserum  (anti-SIRP,  catalog  no.
MAB1407P; Millipore, Billerica, MA) for 10 min and then
centrifuged. The pellet was resuspended in 0.5 mg/ml BSA
solution, and placed in a dish pre-coated with affinity-purified
goat  anti-mouse  IgG  (H+L)  antibody  for  45  min  at  room
temperature. The plate was agitated every 15 min to ensure
good cell adhesion. Non-adherent cells were transferred to the
second  dish  pre-coated  with  goat  anti-mouse  IgG  and
incubated for another 30 min. The non-adherent cells were
passed through a Nitex mesh filter (20 µm pore size; Wildco,
Buffalo, NY) to obtain single cells, then put in the dish pre-
coated with mouse anti-rat Thy1.1 antibody and incubated for
1 h with agitation every 20 min. After removal of non-adherent
cells (collected for non-RGC testing), the dish was washed
three times with PBS. Adherent cells were then detached by
trypsinization using 0.05% trypsin (1:250; Invitrogen) with
0.53 mM EDTA.Na2 (Sigma) in PBS for 5 min at 37 °C. The
cells were collected in Neurobasal medium with 1 mg/ml
trypsin  inhibitor  (Sigma)  and  centrifuged  to  obtain  a  cell
pellet.
After washing with PBS, the cells were resuspended in
serum-free Neurobasal medium with 1% BSA, selenium (6.7
ng/ml;  Sigma),  transferrin  (5.5  μg/ml;  Sigma),  putrescine
(60 μM; Sigma), 3,5,3-triiodothyronine T3 (100 nM; Sigma),
progesterone  (20  nM;  Sigma),  B27  (Invitrogen),  sodium
pyruvate (1 mM; Invitrogen), glutamine (2 mM; Invitrogen),
brain-derived  neurotrophic  factor  (BDNF,  50  ng/ml;
PeproTech,  Rocky  Hill,  NJ),  ciliary  neurotrophic  factor
(CNTF, 10 ng/ml; PeproTech) and forskolin (5 μM; Sigma)
and antibiotics added, and plated at a density of 5,000 cells/
cm2 on a surface pre-coated with poly-L-lysine and laminin.
The medium was replenished every 3 days.
Cell viability: Isolated cells showing neurite outgrowth were
viewed by adding 1 µM calcein-acetoxymethyl ester (calcein-
AM; Molec Probes, Eugene, OR) in PBS for 60 min at 37 °C
and  then  examining  under  fluorescence  microscopy
(excitation wavelength at 365 nm; emission wavelength at 430
nm; DMIRS; Leica, Wetzlar, Germany). The cells with typical
neurite outgrowth were quantified and percentage of viability
was obtained at different time points. The experiment was
performed in triplicate.
Immunocytochemistry:  Cells  were  plated  in  Lab-Tek  8-
chamber  slides  (EMS,  Hatfield,  PA)  and  fixed  in  freshly
prepared 4% neutral buffered paraformaldehyde (Sigma) for
20  min.  After  PBS  washes,  they  were  permeabilized  and
blocked with PBS containing 0.1% Triton X-100 (Sigma) and
1% BSA for 10 min, followed by incubation with mouse
monoclonal anti-human Thy-1 antibody (Santa Cruz Biotech.,
Santa Cruz, CA), mouse monoclonal anti-human βIII tubulin
(Sigma), mouse monoclonal anti-human Brn3a (Chemicon),
mouse  monoclonal  anti-human  HPC-1  (Dako,  Glostrup,
Denmark),  or  rabbit  polyclonal  anti-human  glial  fibrillary
acidic protein (GFAP; Dako) for 2 h at room temperature.
After  washing,  the  samples  were  incubated  with  Cy3-
conjugated  goat  anti-mouse  or  anti-rabbit  IgG  (Jackson
ImmunoRes Lab) for 1 h and then rinsed with PBS. The
samples were mounted in ProLong Antifade solution (Molec
Probes) and examined by confocal microscopy.
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Primary human fetal RGC: Human fetal retinal tissue was
dissociated with collagenase and papain to single cells, which
were  subjected  to  a  two-step  immunopanning  protocol  to
obtain an enriched population of RGCs. The cells were then
propagated in a serum-free medium with supplements. At 24
h post-plating, more than 70% of the primary cells attached to
the culture surface coated with laminin and poly-L-lysine.
Through observation after calcein-AM staining, it was noted
that  most  cells  were  oval  in  shape  with  little  dendritic
outgrowth (Figure 1A). At day 7, dendritic elongation from
isolated  RGCs  was  evident  (Figure  1B)  and  similar
observation was found in the majority of adherent cells. At
day 21, most cells developed a complex dendritic network
with the appearance of numerous neurites and branchings
(Figure 1C,D). These primary human RGCs with extended
neurites were maintained for up to one month in culture with
the  replenishment  of  fresh  medium  every  3  to  4  days.
Quantification  of  calcein-AM-stained  RGC  cells  showing
neurites revealed that the viability declined with time (Figure
1E). Viability was approximately 50% at day 3 in culture and
gradually reduced to about 25% at day 30, which was the
longest time point in our examination.
Characterization of primary human RGCs in culture: At days
3 and 7 of the first passage, primary RGCs were collected for
immunocytochemistry  of  various  RGC  markers.
Membranous staining of Thy1.1 was observed in the region
of the soma and neurites (Figure 2B). DAPI nuclear staining
to reveal RGCs is shown in Figure 2A and a merged image of
Thy1.1 and DAPI is shown in Figure 2C. Immunoreactivity
Figure  1.  Isolated  human  retinal
ganglion cells (RGCs) in culture. A-D:
Morphological changes of human RGCs
in serum-free defined culture at different
time  intervals.  The  cell  bodies  and
neurites were examined by calcein-AM
staining. (A) day 1; (B) day 7; (C) day
21 at lower magnification; (D) day 21 at
higher magnification. E: Percentage of
surviving  RGCs  over  time.
Approximately  50%  of  the  RGCs
survived after the first 3 days in culture.
The  survival  percentages  were
moderately reduced and maintained at
about 20% after 1 month. Experiments
were performed in triplicate. Error bars:
SD. Scale bars: (A, B, D) 50 µm, (C) 25
µm.
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neurites (Figure 2E) and compared to DAPI nuclear staining
(Figure  2D)  (merged  picture  in  Figure  2F).  By  confocal
microscopy, co-expression of Thy1.1 and Brn3a was observed
in the RGCs at day 3. Thy1.1 was found on cell surfaces
(Figure 2H), whereas Brn3a was found predominantly in the
nuclei (Figure 2G) (merged picture in Figure 2I). At day 7,
TUJ1 and Brn3a were detectable in RGCs (Figure 2J-L). To
exclude the possibility of the presence of Muller or amacrine
cells, we stained the cells for the expression of GFAP (marker
for Muller cells) and HPC-1/syntaxin (marker for amacrine
cells). The immunoreactivity of GFAP and HPC-1 was not
Figure 2. Expression of human retinal ganglion cell (RGC)-specific markers. A-F: Immunofluorescence of human RGCs at day 3 of culture
shows positive expression of Thy-1 (B) and TUJ1 (E). DAPI nuclear staining is shown in (A) and (D) and in the merged images in (C) and
(F). Confocal double immunofluorescence shows the co-staining of Brn3a (G) and Thy1 (H) in cells at day 3 of culture (merged image in
I), and Brn3a (J) and TUJI (K) in cells at day 7 (merged image in L). Scale bars: 25 µm.
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normal rat retinas (data not shown).
DISCUSSION
Cultured RGCs will be an important and almost indispensable
tool  for  the  study  of  retinal  visual  physiology  and
pathophysiology  and  it  may  easily  evolve  as  state-of-art
technology for studying the inter- or intra-cellular processes
associated with various retinopathies and neuropathies [3].
Several cell culture models, including mixed retinal cells from
neonatal  or  adult  retinas  [9,12],  purified  RGCs  [10],
transformed RGC cell lines [13], and retinal explant cells have
been established in attempts to study retinal pathophysiology
[14,15].  However,  most  studies  had  the  shortcoming  of
species difference as the established cell cultures originated
from rat or pig [16,17]. Therefore, there is an escalating need
for the establishment of simple, reproducible, and reliable
human RGC isolation and culture protocols with higher yield,
better efficiency, good viability, and a longer period of RGC
feature maintenance, for the sake of further research on retinal
physiology  and  a  better  understanding  of  human  retinal
diseases.
Attempts to cultivate human RGCs with organ culture
have been made but neurite outgrowth from explants was not
observed [8]. When retina is mechanically dissected before
culture, cells have poor viability. Supplementation of basic
fibroblast growth factor allows cells to have better attachment
and dendritic outgrowth with morphology similar to innate
RGCs. However, problems with mixed growth of different
retinal cell types and poor viability still persist. In the absence
of a suitable in vitro RGC model, chemokine and toxicology
studies  on  human  RGCs  had  to  be  performed  by
immunohistochemistry  methods  in  intact  tissues,  which
presents its own pitfalls [18], such as antigenicity changes due
to fixation and processing, epitope masking, and generation
of  non-specific  backgrounds,  from  which  result
reproducibility and proper interpretation might be affected.
We  have  demonstrated  a  two-step  immunopanning
protocol to isolate human RGCs from fetal retinal tissues. The
RGCs in culture showed dendritic outgrowth and elongation
with axonal processes frequently contacting each other. They
did not divide, and hence, the viability dropped over time, until
about  25%  at  day  30  of  culture.  The  cells  were
immunoreactive for RGC specific markers (Thy-1, TUJ-1,
and  Brn3a).  Thy-1  is  a  surface  glycoprotein  of  the
immunoglobulin  superfamily  and  has  been  shown  to
specifically express in RGCs [19]. The expression of Thy-1
in our cultured RGCs was similar to RGCs maintained in vivo
[9].  TUJ1  (neuronal  class  III  β-tubulin)  is  expressed  in
microtubules derived from rat brain and RGCs but not in
retinal  glial  cells  [20].  Brn3a  is  a  class  IV  POU  domain
transcription factor responsible for the development of RGCs
when ectopically expressed in retinal progenitor cells [21,
22]. Our cultured cells were immuno-negative for Muller cell
marker GFAP and amacrine cell marker HPC-1. In general,
the expression pattern of these markers indicated that our
culture method yielded a highly enriched RGC population.
This adherent culture of isolated human RGCs may allow
the  observation  of  growing  dendrites.  Quantitative
parameters, such as neurite length, spanning area of neurites,
and number and hierarchy of neurite branching, can be easily
assessed by a vital staining protocol. Herein, we stained RGC
bodies  and  neurites  with  calcein-AM,  which  became
fluorescent  when  activated  by  an  intracellular  esterase  in
viable cells [23].
Continuous culture of RGCs or other adult CNS neurons
is usually restricted by the post-mitotic characteristics of cells.
In  normal  culture  conditions,  they  do  not  divide,  unless
transformed with onco-genes or virus. Thus, the maintenance
of cells with the preservation of initial phenotypes may be the
most  critical  issue  in  RGC  isolation.  Our  procedure  was
robust, since the isolated RGCs were maintained in “long-
term” culture (which is defined as more than one week in most
literature [4]) with expression of a panel of RGC-specific
phenotypes. Because the RGC yield is greatly affected by
lengthy  post-mortem  procedures  and  tissue  handling,  our
study  recruited  human  fetal  eyes  obtained  2  to  4  h  after
abortion. We dissociated the retinal tissues with an enzyme
cocktail (70 U/ml crude collagenase, 15 U/ml papain in the
presence of 0.2 mg/ml L-cysteine) for 10 min to single cells.
This was 20 to 35 min shorter than previous reports isolating
rat RGCs [10,24] and 50 min shorter than one for human
RGCs [8]. This could account for the better cell survival and
the capacity for neurite outgrowth. From enzymatic digestion
of a single fetal retina, we obtained approximately 6×107
retinal  cells  of  mixed  types.  This  was  enriched  to  about
5×105  RGCs  after  the  two-step  immunopanning  isolation
procedure. Moreover, we found no difference in the isolation
efficiency of human RGCs with the use of anti-human Thy-1
(Chemicon)  or  anti-rat  Thy-1.1  (Chemicon).  For  cost
efficiency and result consistency, we recommend using anti-
rat Thy-1.1 for RGC enrichment.
Our isolation protocol was developed and modified based
on that used for the isolation of rat RGCs [10,24]. We prepared
sterile culture dishes for immunopanning by first coating with
an affinity-purified IgG (H+L) antibody, followed by another
coating with anti-SIRP and anti-rat Thy-1.1. This contributed
to more efficient trapping and a higher yield of RGC-like cells.
We also prolonged the incubation time in the panning steps
from 30 min to 1 h. In our serum-free defined culture with the
common RGC survival factors (such as BDNF, CNTF, B27,
and forskolin) in Neurobasal medium, we supplemented with
selenium, putrescine, thryoxine, triiodothyronine, transferrin,
and  progesterone  (collectively  known  as  Botterstein-Sato
formula) [25]. This resulted in a higher yield of enriched
RGCs and promoted their survival and long-term maintenance
in culture.
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yield  and  efficiency  provided  an  important  laboratory
protocol for the study of the effect of various biochemical or
pharmacological factors on these important visual pathway
cells,  undoubtedly  enhancing  our  understanding  of  the
pathophysiology of blindness and common eye diseases, such
as glaucoma or age-related macular degeneration. This novel
RGC  culture  procedure  could  prove  valuable  in  future
molecular,  cellular,  physiologic,  pathophysiological,  and
pharmacological studies, and in almost every other branch of
basic and clinical research pertaining to RGC-related ocular
diseases.
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